Healthcare
Kartesia takes control of ADL Biopharma
Company's board of directors is reduced to three seats and Ignacio Urbelz is appointed as new CEO
Siparex buys Winncare from IDI
Capza takes part in the deal alongside Siparex and acquires a minority stake
Multiples Heatmap: average pricing hits 11x in busy Q4
Healthcare, financial services and TMT assets continue to drive valuations up, while Nordic and UK regions see highest multiples
Advent Life Sciences raises $215m across two new funds
Funds invest in early- and mid-stage life sciences companies developing new therapeutics and technologies
VC-backed Apcintex acquired by Centessa
Centessa was launched this week following the merger of 10 private biotechnology companies, including Apcintex
Heal Capital invests in Actio
New investment of €1.5m is an extension of the €8.5m raised by the live coaching company in December 2020
Sofinnova, Ally Bridge lead $108m Mainstay round
Mainstay intends to use the funds to support the company's commercial launch of ReActiv8 in the US
Holland Capital, Join Capital invest in RheoCube
GPs are investing more than $2m in the laboratory research and development simulation software
CVC acquires System C – report
William Blair advised on the sale process, which was marketed based on £80m sales and £15m EBITDA
Video: Healthcare Sector Focus virtual event
Expert speakers discuss the short-term impacts of Covid-19, as well as the longer-term effect on traditional healthcare infrastructure
Braavos leads SpyBiotech's $32.5m series-A
Proceeds will advance the clinical development of SpyBiotech's vaccine technology platform
Kurma et al. invest in MedLumics
Investment is part of a larger round led by Asabys Partners, along with VI Partners and CDTI Innvierte
Silver Lake, Nestlé lead €3.5bn investment in IVC Evidensia
Existing owner EQT partially exits its stake from EQT VII, but reinvests through EQT IX
MTIP, Akilia et al. invest in Koa Health
Company intends to use the fresh capital to accelerate its product development and further expand internationally
Soleus leads $35m series-C extension for Inivata
Investment will primarily be used to accelerate the clinical development and rollout of RaDaR
SHS to launch new fund, make 3-4 deals in 2021
Managing partner Sascha Alilovic and partner Manfred Ulmer-Weber speak to Unquote about the firm's expectations for 2021
Advent, Columbus lead €22.6m round for Highlight Therapeutics
Company intends to use the fresh capital to further develop its drug candidate BO-112
BGF sells Renal Services
During BGF's holding period, James Buckley joined the company as non-executive chairman
JB Capital sells Vitaldent Italia to BC Partners' DentalPro
Acquisition is financed through an equity investment by BC Partners and DentalPro's other shareholders
Schroders sells portfolio of seven assets to Rosetta for £49m
Immunocore recently filed for an IPO, and, in light of this news, Shcroders has agreed an earn-out
Register for the Healthcare Sector Focus virtual event
Our expert speakers will discuss the short-term impacts of Covid-19, as well as the longer-term effect on traditional healthcare infrastructure
Nordic Capital launches $2bn take-over for Advanz
Advanz Pharma initially hired Jefferies to advise on a sale process in October 2020
Sagard buys Nutrisens from Evolem, Unigrains
Nutrisens management team, led by CEO Georges Devesa, retains a significant stake in the company
Limerston-backed Prism acquires Repose
GP bought Prism via its debut fund, Limerston Capital Partners I, which closed in 2017 on £220m
